← Leaderboards
Steven Sucheck
University Of Toledo
$3,381,496
Attributed
$6,762,991
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $982.9K · FY2011–24$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,762,991 · 4
By mechanism
R01$6,005,390 · 2
R21$422,950 · 1
R15$334,651 · 1
Top collaborators
- Donald R Ronning10 shared
- Katherine A Wall6 shared
- Kyle H Rohde2 shared
Most similar at University Of Toledo
Same institution · by research overlap
- Donald R Ronning$2,653,771
- Katherine A Wall$1,757,261
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensBasePolysaccharidesProductionMolecularComplexPlayIn VivoBacteriaPositioning AttributePathway InteractionsTuberculosisDrug ResistanceMycobacterialDesignGenus MycobacteriumDrug TargetingCell WallIn VitroMycobacterium TuberculosisCysteineLipidsCarbohydratesCessation Of Life
Grant awards (18)
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity$465,901
R01 · FY2024 · AI · contact PI
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity$442,697
R01 · FY2023 · AI · contact PI
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity$442,697
R01 · FY2022 · AI · contact PI
Mycobacterial trehalose metabolism as drug targets$407,216
R01 · FY2022 · AI
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity$436,677
R01 · FY2021 · AI · contact PI
Mycobacterial trehalose metabolism as drug targets$420,179
R01 · FY2021 · AI
Methods to synthesize oligosaccharide-fusion protein conjugates and enhancement of their antigenicity$550,227
R01 · FY2020 · AI · contact PI
Mycobacterial trehalose metabolism as drug targets$432,647
R01 · FY2020 · AI
Mycobacterial trehalose metabolism as drug targets$259,504
R01 · FY2019 · AI
Synthesis of natural product scaffold selectively active against dormant Mycobacterium tuberculosis$186,625
R21 · FY2019 · AI · contact PI
Mycobacterial trehalose metabolism as drug targets.$179,820
R01 · FY2019 · AI
Mycobacterial trehalose metabolism as drug targets.$423,750
R01 · FY2018 · AI
Synthesis of natural product scaffold selectively active against dormant Mycobacterium tuberculosis$236,325
R21 · FY2018 · AI · contact PI
Understanding trehalose synthesis and utilization in mycobacteria$459,950
R01 · FY2016 · AI
Understanding trehalose synthesis and utilization in mycobacteria$368,750
R01 · FY2015 · AI
Understanding trehalose synthesis and utilization in mycobacteria$368,750
R01 · FY2014 · AI
Understanding trehalose synthesis and utilization in mycobacteria$346,625
R01 · FY2013 · AI
Synthesis of Glycopeptide-Based Cancer Antigen Vaccines$334,651
R15 · FY2011 · GM · contact PI